Marc Carrier/LinkedIn;Caterina E. Marx
/researchgate.net
Apr 17, 2026, 12:44
Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Managing recurrent VTE despite anticoagulation in patients with cancer remains one of the most challenging scenarios in thrombosis care.
This ‘How I Treat’ review outlines a pragmatic potential approach:
- Confirm true recurrence (versus residual clot)
- Assess adherence, drug interactions, and absorption
- Optimize anticoagulation (LMWH escalation or switch)
Despite these strategies, recurrence and bleeding risks remain substantial highlighting the urgent need for more high-quality data.”
Title: How I treat breakthrough thrombosis in patients with cancer
Authors: Caterina E. Marx, Marc Carrier
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion